Höglinger GU. Neuropathology of progressive supranuclear palsy after treatment with tilavonemab - Author's reply. Lancet Neurol. 2021 Oct;20(10):787-788. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Tilavonemab